NASDAQ · PRTAHealthcarePharmaceuticals

Prothena news

$8.78+0.69%

Close Sep 29, 2026 · split-adjusted

Articles · 30 days0English, de-duplicated

Positive0

Neutral0

Negative0

About Prothena

No recent articles focused on Prothena.

Also mentions PRTA

Articles that tag PRTA but are mainly about other companies.

Transthyretin Amyloidosis Treatment Market Size to Reach USD 35.10 Billion by 2035, Growing at a 14.64% CAGR | SNS Insider

GlobeNewswire Inc.Jul 7, 6:42 AM ETNeutral

Listed as leading market player but no specific recent developments or clinical achievements mentioned in the article

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology